program: Cancer Biology

Congratulations to one of our Cellular and Structural Biology graduate program alumni, Nourhan Abdelfattah, Ph.D. who has just received a two-year Horizon Award (total costs, ~$250,000) from the Department of Defense FY19 Peer Reviewed Cancer Research Program! Nour is currently... Read More →

UT Health San Antonio is committed to training tomorrow’s talent, who are relentlessly pursuing discoveries that translate into life-changing, life-saving technologies. Critical to these breakthroughs are our 8 state of the art core lab facilities that create the pathway for... Read More →

Dr. Amelie Ramirez, the Chair of Population and Health Sciences and Associate Director for Community Outreach and Engagement for the Mays Cancer Center within UT Health San Antonio spoke to Kens5 for the article “Why clinical trials about cancer are so important in San... Read More →

Neelam Mukerjee, Ph.D. was selected for an oral presentation and the AAI Trainee Abstract Award from the American Association of Immunologists. The Trainee Abstract Award is a tiered award that provides a higher reimbursement award amount for members with multiple consecutive... Read More →

Patricia Dahia, M.D., Ph.D., professor of medicine, has been awarded a $1 million UT System Faculty STARs award to support her cancer genetics research. Dr. Dahia said the funding will be used to develop the infrastructure of a center for endocrine and hereditary tumors studies.... Read More →

San Antonio, Texas, is attracting a millennial population thanks to its affordability. Watch the video by Fox Business below: https://video.foxbusiness.com/v/6122571511001/ Read More →

A generous donor has provided funds in honor of a long-time hill country resident to support the professional travel of meritorious trainees actively engaged in translational research in cancer biology. Applications are now solicited from UT Health San Antonio students and... Read More →

Dr. Manjeet Rao was recently awarded a grant from National Cancer Institute ($2.1 million) to test the therapeutic efficacy of a novel drug that can inhibit the function of a protein that is highly expressed in cancers. Cancer cells use various mechanisms to manage their survival... Read More →